Granuloma Formation in Pulmonary Sarcoidosis
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 4, 437
- https://doi.org/10.3389/fimmu.2013.00437
Abstract
Sarcoidosis is a granulomatous disorder of unknown cause, affecting multiple organs, but mainly the lungs. The exact order of immunological events remains obscure. Reviewing current literature, combined with careful clinical observations, we propose a model for granuloma formation in pulmonary sarcoidosis. A tight collaboration between macrophages, dendritic cells and lymphocyte subsets, initiates the first steps towards granuloma formation, orchestrated by cytokines and chemokines. In a substantial part of pulmonary sarcoidosis patients, granuloma formation becomes an on-going process, leading to debilitating disease and sometimes death. The immunological response, determining granuloma sustainment is not well understood. An impaired immunosuppressive function of regulatory T cells has been suggested to contribute to the exaggerated response. Interestingly, therapeutical agents commonly used in sarcoidosis, such as glucocorticosteroids and anti-TNF agents, interfere with granuloma integrity and restore the immune homeostasis in autoimmune disorders. Increasing insight into their mechanisms of action may contribute to the search for new therapeutical targets in pulmonary sarcoidosis.Keywords
This publication has 99 references indexed in Scilit:
- TH17 cells in tumour immunity and immunotherapyNature Reviews Immunology, 2010
- Serum Amyloid A Regulates Granulomatous Inflammation in Sarcoidosis through Toll-like Receptor-2American Journal of Respiratory and Critical Care Medicine, 2010
- Functional analysis of dendritic cell–T cell interaction in sarcoidosisClinical and Experimental Immunology, 2009
- The lung vascular filter as a site of immune induction for T cell responses to large embolic antigenThe Journal of Experimental Medicine, 2009
- Cellular Responses to Mycobacterial Antigens Are Present in Bronchoalveolar Lavage Fluid Used in the Diagnosis of SarcoidosisInfection and Immunity, 2009
- Giant cell formation in sarcoidosis: cell fusion or proliferation with non-division?Clinical and Experimental Immunology, 2008
- Reduction of Chemokine Secretion in Response to Mycobacteria in Infliximab-Treated PatientsClinical and Vaccine Immunology, 2008
- Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosisClinical and Experimental Immunology, 2008
- Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosisClinical and Experimental Immunology, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006